BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
Latest Press Release
BONESUPPORT HOLDING AB (publ) – Invitation to Conference Call and Webcast for Year-End Report 2025
2026-02-17
BONESUPPORT HOLDING AB (publ) announces Q4 2025 revenue and provides 2026 outlook
2026-01-13
CERAMENT® V application in the U.S. transferred to the De Novo process
2025-12-02